Viewing Study NCT00026169


Ignite Creation Date: 2025-12-24 @ 10:49 PM
Ignite Modification Date: 2025-12-25 @ 8:18 PM
Study NCT ID: NCT00026169
Status: COMPLETED
Last Update Posted: 2013-01-10
First Post: 2001-11-09
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Imatinib Mesylate in Treating Patients With Advanced Cancer and Kidney Failure
Sponsor: National Cancer Institute (NCI)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module